nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—DRD4—obesity	0.105	0.264	CbGaD
Haloperidol—HTR1B—obesity	0.0931	0.234	CbGaD
Haloperidol—DRD1—obesity	0.0887	0.223	CbGaD
Haloperidol—DRD2—obesity	0.0626	0.157	CbGaD
Haloperidol—DRD1—Phenylpropanolamine—obesity	0.0601	0.186	CbGbCtD
Haloperidol—HTR2A—obesity	0.0483	0.122	CbGaD
Haloperidol—CYP3A7-CYP3A51P—Cimetidine—obesity	0.0188	0.0581	CbGbCtD
Haloperidol—CYP3A7—Cimetidine—obesity	0.0188	0.0581	CbGbCtD
Haloperidol—CYP1A2—Phentermine—obesity	0.0168	0.052	CbGbCtD
Haloperidol—CYP1A2—Phenylpropanolamine—obesity	0.016	0.0496	CbGbCtD
Haloperidol—CYP2C9—Phentermine—obesity	0.0151	0.0468	CbGbCtD
Haloperidol—CYP1A2—Bupropion—obesity	0.0143	0.0442	CbGbCtD
Haloperidol—CYP3A5—Cimetidine—obesity	0.0141	0.0436	CbGbCtD
Haloperidol—CYP2D6—Phentermine—obesity	0.0138	0.0428	CbGbCtD
Haloperidol—CYP2C9—Bupropion—obesity	0.0129	0.0398	CbGbCtD
Haloperidol—CYP2D6—Bupropion—obesity	0.0118	0.0364	CbGbCtD
Haloperidol—CYP3A4—Sibutramine—obesity	0.0116	0.0359	CbGbCtD
Haloperidol—CYP2C19—Cimetidine—obesity	0.0114	0.0351	CbGbCtD
Haloperidol—CYP2D6—Methamphetamine—obesity	0.0111	0.0342	CbGbCtD
Haloperidol—CYP1A2—Cimetidine—obesity	0.0105	0.0324	CbGbCtD
Haloperidol—CYP2C9—Cimetidine—obesity	0.00944	0.0292	CbGbCtD
Haloperidol—ABCB1—Cimetidine—obesity	0.00916	0.0284	CbGbCtD
Haloperidol—CYP3A4—Benzphetamine—obesity	0.0088	0.0272	CbGbCtD
Haloperidol—CYP2D6—Cimetidine—obesity	0.00863	0.0267	CbGbCtD
Haloperidol—CYP3A4—Bupropion—obesity	0.00748	0.0231	CbGbCtD
Haloperidol—CYP2C19—Topiramate—obesity	0.00743	0.023	CbGbCtD
Haloperidol—CYP3A4—Orlistat—obesity	0.0061	0.0189	CbGbCtD
Haloperidol—CYP3A4—Cimetidine—obesity	0.00549	0.017	CbGbCtD
Haloperidol—CYP3A4—Topiramate—obesity	0.00359	0.0111	CbGbCtD
Haloperidol—GRIN2B—hindbrain—obesity	0.00167	0.0456	CbGeAlD
Haloperidol—HTR2A—sympathetic nervous system—obesity	0.00138	0.0377	CbGeAlD
Haloperidol—HTR2A—vagus nerve—obesity	0.00134	0.0365	CbGeAlD
Haloperidol—HTR2A—autonomic nervous system—obesity	0.000929	0.0253	CbGeAlD
Haloperidol—EBP—endocrine gland—obesity	0.000874	0.0238	CbGeAlD
Haloperidol—CBR1—islet of Langerhans—obesity	0.000803	0.0219	CbGeAlD
Haloperidol—EBP—liver—obesity	0.000788	0.0215	CbGeAlD
Haloperidol—CBR1—respiratory system—obesity	0.000758	0.0207	CbGeAlD
Haloperidol—H1F0—islet of Langerhans—obesity	0.000658	0.0179	CbGeAlD
Haloperidol—UGT1A9—digestive system—obesity	0.000641	0.0175	CbGeAlD
Haloperidol—CBR1—adrenal cortex—obesity	0.000636	0.0173	CbGeAlD
Haloperidol—H1F0—respiratory system—obesity	0.000621	0.0169	CbGeAlD
Haloperidol—DRD2—hindbrain—obesity	0.000593	0.0162	CbGeAlD
Haloperidol—CBR1—cardiovascular system—obesity	0.000581	0.0158	CbGeAlD
Haloperidol—GRIN2B—endocrine gland—obesity	0.000537	0.0146	CbGeAlD
Haloperidol—UGT1A9—endocrine gland—obesity	0.000529	0.0144	CbGeAlD
Haloperidol—H1F0—adrenal cortex—obesity	0.000521	0.0142	CbGeAlD
Haloperidol—CBR1—pituitary gland—obesity	0.000514	0.014	CbGeAlD
Haloperidol—CBR1—adipose tissue—obesity	0.000512	0.014	CbGeAlD
Haloperidol—CBR1—digestive system—obesity	0.000482	0.0131	CbGeAlD
Haloperidol—UGT1A9—liver—obesity	0.000477	0.013	CbGeAlD
Haloperidol—H1F0—cardiovascular system—obesity	0.000476	0.013	CbGeAlD
Haloperidol—SIGMAR1—islet of Langerhans—obesity	0.000475	0.013	CbGeAlD
Haloperidol—CBR1—adrenal gland—obesity	0.000459	0.0125	CbGeAlD
Haloperidol—CYP3A7—endocrine gland—obesity	0.00044	0.012	CbGeAlD
Haloperidol—H1F0—pituitary gland—obesity	0.000421	0.0115	CbGeAlD
Haloperidol—H1F0—adipose tissue—obesity	0.00042	0.0114	CbGeAlD
Haloperidol—Loperamide—POMC—obesity	0.000403	0.131	CrCbGaD
Haloperidol—CBR1—endocrine gland—obesity	0.000398	0.0109	CbGeAlD
Haloperidol—CYP3A7—liver—obesity	0.000397	0.0108	CbGeAlD
Haloperidol—H1F0—digestive system—obesity	0.000395	0.0108	CbGeAlD
Haloperidol—HTR2A—hindbrain—obesity	0.000391	0.0107	CbGeAlD
Haloperidol—HTR1B—cardiovascular system—obesity	0.000381	0.0104	CbGeAlD
Haloperidol—KCNH2—islet of Langerhans—obesity	0.000378	0.0103	CbGeAlD
Haloperidol—SIGMAR1—adrenal cortex—obesity	0.000377	0.0103	CbGeAlD
Haloperidol—H1F0—adrenal gland—obesity	0.000376	0.0103	CbGeAlD
Haloperidol—HTR2B—adrenal cortex—obesity	0.000376	0.0102	CbGeAlD
Haloperidol—HTR1D—cardiovascular system—obesity	0.000369	0.01	CbGeAlD
Haloperidol—DRD2—respiratory system—obesity	0.000362	0.00988	CbGeAlD
Haloperidol—CBR1—liver—obesity	0.000359	0.00979	CbGeAlD
Haloperidol—CYP2D6—hindbrain—obesity	0.000357	0.00972	CbGeAlD
Haloperidol—HTR2B—cardiovascular system—obesity	0.000343	0.00935	CbGeAlD
Haloperidol—CYP3A7-CYP3A51P—liver—obesity	0.000337	0.0092	CbGeAlD
Haloperidol—H1F0—endocrine gland—obesity	0.000326	0.0089	CbGeAlD
Haloperidol—Sertindole—DRD4—obesity	0.000314	0.102	CrCbGaD
Haloperidol—CYP3A5—islet of Langerhans—obesity	0.000312	0.00851	CbGeAlD
Haloperidol—CYP1A2—respiratory system—obesity	0.000306	0.00833	CbGeAlD
Haloperidol—SIGMAR1—pituitary gland—obesity	0.000304	0.00829	CbGeAlD
Haloperidol—SIGMAR1—adipose tissue—obesity	0.000303	0.00826	CbGeAlD
Haloperidol—HTR2B—adipose tissue—obesity	0.000302	0.00824	CbGeAlD
Haloperidol—CYP1A1—respiratory system—obesity	0.000302	0.00822	CbGeAlD
Haloperidol—CYP3A5—respiratory system—obesity	0.000295	0.00804	CbGeAlD
Haloperidol—H1F0—liver—obesity	0.000294	0.00802	CbGeAlD
Haloperidol—Droperidol—DRD2—obesity	0.00029	0.0946	CrCbGaD
Haloperidol—HRH1—respiratory system—obesity	0.000286	0.0078	CbGeAlD
Haloperidol—HTR2B—digestive system—obesity	0.000285	0.00776	CbGeAlD
Haloperidol—Sertindole—HTR1B—obesity	0.000279	0.0907	CrCbGaD
Haloperidol—KCNH2—cardiovascular system—obesity	0.000274	0.00746	CbGeAlD
Haloperidol—SIGMAR1—adrenal gland—obesity	0.000272	0.00741	CbGeAlD
Haloperidol—HTR2B—adrenal gland—obesity	0.000271	0.00739	CbGeAlD
Haloperidol—HTR1B—endocrine gland—obesity	0.000261	0.00712	CbGeAlD
Haloperidol—DRD2—pituitary gland—obesity	0.000246	0.0067	CbGeAlD
Haloperidol—KCNH2—pituitary gland—obesity	0.000242	0.0066	CbGeAlD
Haloperidol—HTR2A—respiratory system—obesity	0.000239	0.00652	CbGeAlD
Haloperidol—CYP2C19—digestive system—obesity	0.000238	0.00649	CbGeAlD
Haloperidol—Sertindole—HTR2C—obesity	0.000227	0.074	CrCbGaD
Haloperidol—Droperidol—HTR2A—obesity	0.000224	0.0731	CrCbGaD
Haloperidol—CYP2C9—cardiovascular system—obesity	0.000222	0.00606	CbGeAlD
Haloperidol—KCNH2—adrenal gland—obesity	0.000216	0.0059	CbGeAlD
Haloperidol—SIGMAR1—liver—obesity	0.000213	0.00579	CbGeAlD
Haloperidol—CYP1A1—adipose tissue—obesity	0.000204	0.00555	CbGeAlD
Haloperidol—Fluspirilene—ADRB1—obesity	0.000201	0.0654	CrCbGaD
Haloperidol—CYP3A5—adipose tissue—obesity	0.000199	0.00543	CbGeAlD
Haloperidol—CYP2C19—endocrine gland—obesity	0.000197	0.00536	CbGeAlD
Haloperidol—CYP1A2—digestive system—obesity	0.000194	0.0053	CbGeAlD
Haloperidol—HRH1—adipose tissue—obesity	0.000193	0.00527	CbGeAlD
Haloperidol—CYP1A1—digestive system—obesity	0.000192	0.00523	CbGeAlD
Haloperidol—Vomiting—Phenylpropanolamine—obesity	0.000191	0.00153	CcSEcCtD
Haloperidol—DRD2—endocrine gland—obesity	0.00019	0.00519	CbGeAlD
Haloperidol—Dizziness—Phentermine—obesity	0.00019	0.00152	CcSEcCtD
Haloperidol—Sweating increased—Bupropion—obesity	0.000189	0.00152	CcSEcCtD
Haloperidol—Rash—Phenylpropanolamine—obesity	0.000189	0.00152	CcSEcCtD
Haloperidol—Dermatitis—Phenylpropanolamine—obesity	0.000189	0.00152	CcSEcCtD
Haloperidol—Sertindole—SLC6A4—obesity	0.000188	0.0613	CrCbGaD
Haloperidol—Mazindol—SLC6A4—obesity	0.000188	0.0613	CrCbGaD
Haloperidol—Body temperature increased—Cimetidine—obesity	0.000188	0.00151	CcSEcCtD
Haloperidol—KCNH2—endocrine gland—obesity	0.000188	0.00511	CbGeAlD
Haloperidol—CYP3A5—digestive system—obesity	0.000187	0.00511	CbGeAlD
Haloperidol—Sertindole—DRD2—obesity	0.000187	0.061	CrCbGaD
Haloperidol—Pancytopenia—Bupropion—obesity	0.000185	0.00148	CcSEcCtD
Haloperidol—Hepatitis—Orlistat—obesity	0.000185	0.00148	CcSEcCtD
Haloperidol—CYP2C9—digestive system—obesity	0.000185	0.00503	CbGeAlD
Haloperidol—HTR2A—cardiovascular system—obesity	0.000183	0.00499	CbGeAlD
Haloperidol—Vomiting—Phentermine—obesity	0.000182	0.00147	CcSEcCtD
Haloperidol—Urinary tract disorder—Orlistat—obesity	0.000182	0.00146	CcSEcCtD
Haloperidol—HRH1—digestive system—obesity	0.000182	0.00496	CbGeAlD
Haloperidol—Urethral disorder—Orlistat—obesity	0.000181	0.00145	CcSEcCtD
Haloperidol—Rash—Phentermine—obesity	0.000181	0.00145	CcSEcCtD
Haloperidol—Dermatitis—Phentermine—obesity	0.000181	0.00145	CcSEcCtD
Haloperidol—Headache—Phentermine—obesity	0.00018	0.00144	CcSEcCtD
Haloperidol—Erectile dysfunction—Bupropion—obesity	0.000179	0.00144	CcSEcCtD
Haloperidol—Nausea—Phenylpropanolamine—obesity	0.000178	0.00143	CcSEcCtD
Haloperidol—Photosensitivity reaction—Bupropion—obesity	0.000178	0.00143	CcSEcCtD
Haloperidol—CYP2C19—liver—obesity	0.000177	0.00483	CbGeAlD
Haloperidol—Weight increased—Bupropion—obesity	0.000177	0.00142	CcSEcCtD
Haloperidol—Weight decreased—Bupropion—obesity	0.000176	0.00141	CcSEcCtD
Haloperidol—Hyperglycaemia—Bupropion—obesity	0.000175	0.00141	CcSEcCtD
Haloperidol—Hypersensitivity—Cimetidine—obesity	0.000175	0.00141	CcSEcCtD
Haloperidol—HRH1—adrenal gland—obesity	0.000173	0.00473	CbGeAlD
Haloperidol—Hypertonia—Topiramate—obesity	0.000173	0.00139	CcSEcCtD
Haloperidol—Hyperkinesia—Topiramate—obesity	0.000172	0.00138	CcSEcCtD
Haloperidol—Visual impairment—Sibutramine—obesity	0.000172	0.00138	CcSEcCtD
Haloperidol—Diarrhoea—Diethylpropion—obesity	0.000171	0.00137	CcSEcCtD
Haloperidol—Nausea—Phentermine—obesity	0.00017	0.00137	CcSEcCtD
Haloperidol—Euphoric mood—Topiramate—obesity	0.00017	0.00136	CcSEcCtD
Haloperidol—Jaundice—Bupropion—obesity	0.000169	0.00136	CcSEcCtD
Haloperidol—Eye disorder—Sibutramine—obesity	0.000167	0.00134	CcSEcCtD
Haloperidol—Immune system disorder—Orlistat—obesity	0.000167	0.00134	CcSEcCtD
Haloperidol—Mediastinal disorder—Orlistat—obesity	0.000166	0.00134	CcSEcCtD
Haloperidol—ABCB1—islet of Langerhans—obesity	0.000166	0.00452	CbGeAlD
Haloperidol—Dizziness—Diethylpropion—obesity	0.000165	0.00133	CcSEcCtD
Haloperidol—Alopecia—Orlistat—obesity	0.000163	0.00131	CcSEcCtD
Haloperidol—Diarrhoea—Cimetidine—obesity	0.000162	0.00131	CcSEcCtD
Haloperidol—HTR2A—pituitary gland—obesity	0.000162	0.00442	CbGeAlD
Haloperidol—Angiopathy—Sibutramine—obesity	0.000162	0.0013	CcSEcCtD
Haloperidol—Mental disorder—Orlistat—obesity	0.000162	0.0013	CcSEcCtD
Haloperidol—Immune system disorder—Sibutramine—obesity	0.000161	0.0013	CcSEcCtD
Haloperidol—Malnutrition—Orlistat—obesity	0.000161	0.00129	CcSEcCtD
Haloperidol—CYP1A2—endocrine gland—obesity	0.000161	0.00438	CbGeAlD
Haloperidol—Vomiting—Diethylpropion—obesity	0.000159	0.00127	CcSEcCtD
Haloperidol—CYP1A1—endocrine gland—obesity	0.000158	0.00432	CbGeAlD
Haloperidol—Alopecia—Sibutramine—obesity	0.000158	0.00127	CcSEcCtD
Haloperidol—Rash—Diethylpropion—obesity	0.000157	0.00126	CcSEcCtD
Haloperidol—Dermatitis—Diethylpropion—obesity	0.000157	0.00126	CcSEcCtD
Haloperidol—Dizziness—Cimetidine—obesity	0.000157	0.00126	CcSEcCtD
Haloperidol—ABCB1—respiratory system—obesity	0.000157	0.00427	CbGeAlD
Haloperidol—Headache—Diethylpropion—obesity	0.000156	0.00126	CcSEcCtD
Haloperidol—Hepatitis—Bupropion—obesity	0.000156	0.00125	CcSEcCtD
Haloperidol—Malnutrition—Sibutramine—obesity	0.000155	0.00125	CcSEcCtD
Haloperidol—Hallucination—Bupropion—obesity	0.000155	0.00124	CcSEcCtD
Haloperidol—CYP3A5—endocrine gland—obesity	0.000155	0.00422	CbGeAlD
Haloperidol—Libido decreased—Topiramate—obesity	0.000155	0.00124	CcSEcCtD
Haloperidol—Muscle spasms—Orlistat—obesity	0.000154	0.00124	CcSEcCtD
Haloperidol—Urinary tract disorder—Bupropion—obesity	0.000154	0.00124	CcSEcCtD
Haloperidol—Fluspirilene—SLC6A4—obesity	0.000153	0.05	CrCbGaD
Haloperidol—Connective tissue disorder—Bupropion—obesity	0.000153	0.00123	CcSEcCtD
Haloperidol—Urethral disorder—Bupropion—obesity	0.000153	0.00123	CcSEcCtD
Haloperidol—Fluspirilene—DRD2—obesity	0.000153	0.0497	CrCbGaD
Haloperidol—CYP2C9—endocrine gland—obesity	0.000152	0.00416	CbGeAlD
Haloperidol—HTR2A—digestive system—obesity	0.000152	0.00414	CbGeAlD
Haloperidol—Vision blurred—Orlistat—obesity	0.000151	0.00122	CcSEcCtD
Haloperidol—Visual disturbance—Topiramate—obesity	0.000151	0.00122	CcSEcCtD
Haloperidol—Vomiting—Cimetidine—obesity	0.000151	0.00121	CcSEcCtD
Haloperidol—HRH1—endocrine gland—obesity	0.00015	0.0041	CbGeAlD
Haloperidol—Visual impairment—Bupropion—obesity	0.00015	0.00121	CcSEcCtD
Haloperidol—Rash—Cimetidine—obesity	0.00015	0.0012	CcSEcCtD
Haloperidol—Dermatitis—Cimetidine—obesity	0.00015	0.0012	CcSEcCtD
Haloperidol—Muscle spasms—Sibutramine—obesity	0.000149	0.0012	CcSEcCtD
Haloperidol—Headache—Cimetidine—obesity	0.000149	0.0012	CcSEcCtD
Haloperidol—Nausea—Diethylpropion—obesity	0.000148	0.00119	CcSEcCtD
Haloperidol—Hypoglycaemia—Topiramate—obesity	0.000147	0.00118	CcSEcCtD
Haloperidol—Vision blurred—Sibutramine—obesity	0.000147	0.00118	CcSEcCtD
Haloperidol—Lethargy—Topiramate—obesity	0.000146	0.00118	CcSEcCtD
Haloperidol—Tremor—Sibutramine—obesity	0.000146	0.00117	CcSEcCtD
Haloperidol—Eye disorder—Bupropion—obesity	0.000146	0.00117	CcSEcCtD
Haloperidol—HTR2A—adrenal gland—obesity	0.000145	0.00395	CbGeAlD
Haloperidol—CYP1A2—liver—obesity	0.000145	0.00395	CbGeAlD
Haloperidol—Sertindole—HTR2A—obesity	0.000145	0.0471	CrCbGaD
Haloperidol—Cardiac disorder—Bupropion—obesity	0.000145	0.00116	CcSEcCtD
Haloperidol—Vertigo—Orlistat—obesity	0.000144	0.00116	CcSEcCtD
Haloperidol—Hyponatraemia—Topiramate—obesity	0.000144	0.00116	CcSEcCtD
Haloperidol—Anaemia—Sibutramine—obesity	0.000144	0.00115	CcSEcCtD
Haloperidol—Agitation—Sibutramine—obesity	0.000143	0.00115	CcSEcCtD
Haloperidol—CYP1A1—liver—obesity	0.000143	0.00389	CbGeAlD
Haloperidol—Disturbance in sexual arousal—Topiramate—obesity	0.000142	0.00114	CcSEcCtD
Haloperidol—Angiopathy—Bupropion—obesity	0.000141	0.00113	CcSEcCtD
Haloperidol—Nausea—Cimetidine—obesity	0.000141	0.00113	CcSEcCtD
Haloperidol—CYP3A4—digestive system—obesity	0.000141	0.00384	CbGeAlD
Haloperidol—Immune system disorder—Bupropion—obesity	0.000141	0.00113	CcSEcCtD
Haloperidol—Mediastinal disorder—Bupropion—obesity	0.00014	0.00113	CcSEcCtD
Haloperidol—Psychotic disorder—Topiramate—obesity	0.00014	0.00112	CcSEcCtD
Haloperidol—Vertigo—Sibutramine—obesity	0.00014	0.00112	CcSEcCtD
Haloperidol—CYP3A5—liver—obesity	0.00014	0.00381	CbGeAlD
Haloperidol—Convulsion—Orlistat—obesity	0.000139	0.00112	CcSEcCtD
Haloperidol—Leukopenia—Sibutramine—obesity	0.000139	0.00112	CcSEcCtD
Haloperidol—CYP2D6—digestive system—obesity	0.000138	0.00377	CbGeAlD
Haloperidol—Face oedema—Topiramate—obesity	0.000138	0.00111	CcSEcCtD
Haloperidol—Alopecia—Bupropion—obesity	0.000138	0.00111	CcSEcCtD
Haloperidol—CYP2C9—liver—obesity	0.000137	0.00375	CbGeAlD
Haloperidol—Mental disorder—Bupropion—obesity	0.000136	0.0011	CcSEcCtD
Haloperidol—Urinary retention—Topiramate—obesity	0.000136	0.0011	CcSEcCtD
Haloperidol—Anxiety—Orlistat—obesity	0.000136	0.00109	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000136	0.00109	CcSEcCtD
Haloperidol—Malnutrition—Bupropion—obesity	0.000136	0.00109	CcSEcCtD
Haloperidol—Convulsion—Sibutramine—obesity	0.000135	0.00108	CcSEcCtD
Haloperidol—Hypertension—Sibutramine—obesity	0.000134	0.00108	CcSEcCtD
Haloperidol—Dry mouth—Orlistat—obesity	0.000134	0.00107	CcSEcCtD
Haloperidol—Liver function test abnormal—Topiramate—obesity	0.000132	0.00106	CcSEcCtD
Haloperidol—Anxiety—Sibutramine—obesity	0.000132	0.00106	CcSEcCtD
Haloperidol—ABCB1—adrenal cortex—obesity	0.000131	0.00358	CbGeAlD
Haloperidol—Anaphylactic shock—Orlistat—obesity	0.000131	0.00105	CcSEcCtD
Haloperidol—Oedema—Orlistat—obesity	0.000131	0.00105	CcSEcCtD
Haloperidol—Orthostatic hypotension—Topiramate—obesity	0.000131	0.00105	CcSEcCtD
Haloperidol—Muscle spasms—Bupropion—obesity	0.00013	0.00105	CcSEcCtD
Haloperidol—Breast disorder—Topiramate—obesity	0.00013	0.00104	CcSEcCtD
Haloperidol—Dry mouth—Sibutramine—obesity	0.000129	0.00104	CcSEcCtD
Haloperidol—Nervous system disorder—Orlistat—obesity	0.000129	0.00103	CcSEcCtD
Haloperidol—Confusional state—Sibutramine—obesity	0.000128	0.00103	CcSEcCtD
Haloperidol—Vision blurred—Bupropion—obesity	0.000128	0.00103	CcSEcCtD
Haloperidol—Skin disorder—Orlistat—obesity	0.000127	0.00102	CcSEcCtD
Haloperidol—Tremor—Bupropion—obesity	0.000127	0.00102	CcSEcCtD
Haloperidol—Oedema—Sibutramine—obesity	0.000127	0.00102	CcSEcCtD
Haloperidol—Anaphylactic shock—Sibutramine—obesity	0.000127	0.00102	CcSEcCtD
Haloperidol—Hyperhidrosis—Orlistat—obesity	0.000127	0.00102	CcSEcCtD
Haloperidol—HTR2A—endocrine gland—obesity	0.000126	0.00342	CbGeAlD
Haloperidol—Anaemia—Bupropion—obesity	0.000125	0.00101	CcSEcCtD
Haloperidol—Agitation—Bupropion—obesity	0.000125	0.001	CcSEcCtD
Haloperidol—Thrombocytopenia—Sibutramine—obesity	0.000124	0.000998	CcSEcCtD
Haloperidol—Dysphagia—Topiramate—obesity	0.000124	0.000996	CcSEcCtD
Haloperidol—Tachycardia—Sibutramine—obesity	0.000124	0.000995	CcSEcCtD
Haloperidol—Skin disorder—Sibutramine—obesity	0.000123	0.00099	CcSEcCtD
Haloperidol—Hyperhidrosis—Sibutramine—obesity	0.000123	0.000985	CcSEcCtD
Haloperidol—Vertigo—Bupropion—obesity	0.000122	0.000978	CcSEcCtD
Haloperidol—Leukopenia—Bupropion—obesity	0.000121	0.000975	CcSEcCtD
Haloperidol—Anorexia—Sibutramine—obesity	0.000121	0.000972	CcSEcCtD
Haloperidol—Sweating increased—Topiramate—obesity	0.000121	0.00097	CcSEcCtD
Haloperidol—ABCB1—cardiovascular system—obesity	0.00012	0.00327	CbGeAlD
Haloperidol—Insomnia—Orlistat—obesity	0.000119	0.000953	CcSEcCtD
Haloperidol—Hypotension—Sibutramine—obesity	0.000119	0.000952	CcSEcCtD
Haloperidol—Fluspirilene—HTR2A—obesity	0.000118	0.0384	CrCbGaD
Haloperidol—Pancytopenia—Topiramate—obesity	0.000118	0.000945	CcSEcCtD
Haloperidol—Convulsion—Bupropion—obesity	0.000117	0.000943	CcSEcCtD
Haloperidol—Hypertension—Bupropion—obesity	0.000117	0.00094	CcSEcCtD
Haloperidol—CYP3A4—endocrine gland—obesity	0.000116	0.00317	CbGeAlD
Haloperidol—Neutropenia—Topiramate—obesity	0.000116	0.000931	CcSEcCtD
Haloperidol—Dyspepsia—Orlistat—obesity	0.000115	0.000927	CcSEcCtD
Haloperidol—Anxiety—Bupropion—obesity	0.000115	0.000924	CcSEcCtD
Haloperidol—Insomnia—Sibutramine—obesity	0.000115	0.000922	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000115	0.000921	CcSEcCtD
Haloperidol—CYP2D6—endocrine gland—obesity	0.000114	0.00312	CbGeAlD
Haloperidol—Erectile dysfunction—Topiramate—obesity	0.000114	0.000917	CcSEcCtD
Haloperidol—Decreased appetite—Orlistat—obesity	0.000114	0.000916	CcSEcCtD
Haloperidol—HTR2A—liver—obesity	0.000113	0.00309	CbGeAlD
Haloperidol—Gastrointestinal disorder—Orlistat—obesity	0.000113	0.000909	CcSEcCtD
Haloperidol—Dyspnoea—Sibutramine—obesity	0.000113	0.000909	CcSEcCtD
Haloperidol—Photosensitivity reaction—Topiramate—obesity	0.000113	0.000909	CcSEcCtD
Haloperidol—Dry mouth—Bupropion—obesity	0.000113	0.000907	CcSEcCtD
Haloperidol—Somnolence—Sibutramine—obesity	0.000113	0.000906	CcSEcCtD
Haloperidol—Weight increased—Topiramate—obesity	0.000113	0.000906	CcSEcCtD
Haloperidol—Weight decreased—Topiramate—obesity	0.000112	0.000901	CcSEcCtD
Haloperidol—Hyperglycaemia—Topiramate—obesity	0.000112	0.000898	CcSEcCtD
Haloperidol—Dyspepsia—Sibutramine—obesity	0.000112	0.000897	CcSEcCtD
Haloperidol—Confusional state—Bupropion—obesity	0.000112	0.000896	CcSEcCtD
Haloperidol—Anaphylactic shock—Bupropion—obesity	0.000111	0.000889	CcSEcCtD
Haloperidol—Oedema—Bupropion—obesity	0.000111	0.000889	CcSEcCtD
Haloperidol—Decreased appetite—Sibutramine—obesity	0.00011	0.000886	CcSEcCtD
Haloperidol—Depression—Topiramate—obesity	0.00011	0.000885	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Sibutramine—obesity	0.00011	0.00088	CcSEcCtD
Haloperidol—Constipation—Sibutramine—obesity	0.000109	0.000872	CcSEcCtD
Haloperidol—Nervous system disorder—Bupropion—obesity	0.000108	0.000871	CcSEcCtD
Haloperidol—Thrombocytopenia—Bupropion—obesity	0.000108	0.00087	CcSEcCtD
Haloperidol—Feeling abnormal—Orlistat—obesity	0.000108	0.000868	CcSEcCtD
Haloperidol—Tachycardia—Bupropion—obesity	0.000108	0.000867	CcSEcCtD
Haloperidol—Skin disorder—Bupropion—obesity	0.000107	0.000863	CcSEcCtD
Haloperidol—Hyperhidrosis—Bupropion—obesity	0.000107	0.000859	CcSEcCtD
Haloperidol—ABCB1—pituitary gland—obesity	0.000106	0.0029	CbGeAlD
Haloperidol—ABCB1—adipose tissue—obesity	0.000106	0.00288	CbGeAlD
Haloperidol—Anorexia—Bupropion—obesity	0.000105	0.000847	CcSEcCtD
Haloperidol—CYP3A4—liver—obesity	0.000105	0.00286	CbGeAlD
Haloperidol—Feeling abnormal—Sibutramine—obesity	0.000105	0.00084	CcSEcCtD
Haloperidol—Urticaria—Orlistat—obesity	0.000104	0.000837	CcSEcCtD
Haloperidol—Body temperature increased—Orlistat—obesity	0.000104	0.000833	CcSEcCtD
Haloperidol—Hypotension—Bupropion—obesity	0.000103	0.00083	CcSEcCtD
Haloperidol—CYP2D6—liver—obesity	0.000103	0.00281	CbGeAlD
Haloperidol—Agranulocytosis—Topiramate—obesity	0.000103	0.000828	CcSEcCtD
Haloperidol—Urticaria—Sibutramine—obesity	0.000101	0.00081	CcSEcCtD
Haloperidol—Body temperature increased—Sibutramine—obesity	0.0001	0.000806	CcSEcCtD
Haloperidol—Insomnia—Bupropion—obesity	0.0001	0.000804	CcSEcCtD
Haloperidol—ABCB1—digestive system—obesity	9.96e-05	0.00272	CbGeAlD
Haloperidol—Hepatitis—Topiramate—obesity	9.92e-05	0.000797	CcSEcCtD
Haloperidol—Hallucination—Topiramate—obesity	9.87e-05	0.000793	CcSEcCtD
Haloperidol—Dyspnoea—Bupropion—obesity	9.86e-05	0.000792	CcSEcCtD
Haloperidol—Somnolence—Bupropion—obesity	9.83e-05	0.00079	CcSEcCtD
Haloperidol—Urinary tract disorder—Topiramate—obesity	9.8e-05	0.000787	CcSEcCtD
Haloperidol—Connective tissue disorder—Topiramate—obesity	9.75e-05	0.000783	CcSEcCtD
Haloperidol—Dyspepsia—Bupropion—obesity	9.74e-05	0.000782	CcSEcCtD
Haloperidol—Urethral disorder—Topiramate—obesity	9.72e-05	0.000781	CcSEcCtD
Haloperidol—Hypersensitivity—Orlistat—obesity	9.66e-05	0.000776	CcSEcCtD
Haloperidol—Decreased appetite—Bupropion—obesity	9.62e-05	0.000772	CcSEcCtD
Haloperidol—Visual impairment—Topiramate—obesity	9.56e-05	0.000768	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Bupropion—obesity	9.55e-05	0.000767	CcSEcCtD
Haloperidol—ABCB1—adrenal gland—obesity	9.49e-05	0.00259	CbGeAlD
Haloperidol—Constipation—Bupropion—obesity	9.46e-05	0.00076	CcSEcCtD
Haloperidol—Hypersensitivity—Sibutramine—obesity	9.35e-05	0.000751	CcSEcCtD
Haloperidol—Pruritus—Orlistat—obesity	9.28e-05	0.000745	CcSEcCtD
Haloperidol—Eye disorder—Topiramate—obesity	9.27e-05	0.000745	CcSEcCtD
Haloperidol—Cardiac disorder—Topiramate—obesity	9.21e-05	0.00074	CcSEcCtD
Haloperidol—Feeling abnormal—Bupropion—obesity	9.12e-05	0.000732	CcSEcCtD
Haloperidol—Angiopathy—Topiramate—obesity	9e-05	0.000723	CcSEcCtD
Haloperidol—Pruritus—Sibutramine—obesity	8.98e-05	0.000721	CcSEcCtD
Haloperidol—Diarrhoea—Orlistat—obesity	8.97e-05	0.000721	CcSEcCtD
Haloperidol—Immune system disorder—Topiramate—obesity	8.96e-05	0.00072	CcSEcCtD
Haloperidol—Mediastinal disorder—Topiramate—obesity	8.94e-05	0.000718	CcSEcCtD
Haloperidol—Urticaria—Bupropion—obesity	8.79e-05	0.000706	CcSEcCtD
Haloperidol—Alopecia—Topiramate—obesity	8.77e-05	0.000704	CcSEcCtD
Haloperidol—Body temperature increased—Bupropion—obesity	8.75e-05	0.000702	CcSEcCtD
Haloperidol—Mental disorder—Topiramate—obesity	8.69e-05	0.000698	CcSEcCtD
Haloperidol—Diarrhoea—Sibutramine—obesity	8.68e-05	0.000697	CcSEcCtD
Haloperidol—Dizziness—Orlistat—obesity	8.67e-05	0.000696	CcSEcCtD
Haloperidol—Malnutrition—Topiramate—obesity	8.64e-05	0.000694	CcSEcCtD
Haloperidol—Dizziness—Sibutramine—obesity	8.39e-05	0.000674	CcSEcCtD
Haloperidol—Vomiting—Orlistat—obesity	8.34e-05	0.00067	CcSEcCtD
Haloperidol—Muscle spasms—Topiramate—obesity	8.3e-05	0.000667	CcSEcCtD
Haloperidol—Rash—Orlistat—obesity	8.27e-05	0.000664	CcSEcCtD
Haloperidol—Dermatitis—Orlistat—obesity	8.26e-05	0.000663	CcSEcCtD
Haloperidol—ABCB1—endocrine gland—obesity	8.23e-05	0.00224	CbGeAlD
Haloperidol—Headache—Orlistat—obesity	8.21e-05	0.00066	CcSEcCtD
Haloperidol—Hypersensitivity—Bupropion—obesity	8.15e-05	0.000655	CcSEcCtD
Haloperidol—Vision blurred—Topiramate—obesity	8.14e-05	0.000654	CcSEcCtD
Haloperidol—Tremor—Topiramate—obesity	8.09e-05	0.00065	CcSEcCtD
Haloperidol—Vomiting—Sibutramine—obesity	8.07e-05	0.000648	CcSEcCtD
Haloperidol—Rash—Sibutramine—obesity	8e-05	0.000643	CcSEcCtD
Haloperidol—Dermatitis—Sibutramine—obesity	7.99e-05	0.000642	CcSEcCtD
Haloperidol—Anaemia—Topiramate—obesity	7.98e-05	0.000641	CcSEcCtD
Haloperidol—Headache—Sibutramine—obesity	7.95e-05	0.000639	CcSEcCtD
Haloperidol—Agitation—Topiramate—obesity	7.94e-05	0.000637	CcSEcCtD
Haloperidol—Pruritus—Bupropion—obesity	7.83e-05	0.000629	CcSEcCtD
Haloperidol—Nausea—Orlistat—obesity	7.79e-05	0.000626	CcSEcCtD
Haloperidol—Vertigo—Topiramate—obesity	7.76e-05	0.000623	CcSEcCtD
Haloperidol—Leukopenia—Topiramate—obesity	7.73e-05	0.000621	CcSEcCtD
Haloperidol—Diarrhoea—Bupropion—obesity	7.57e-05	0.000608	CcSEcCtD
Haloperidol—Nausea—Sibutramine—obesity	7.54e-05	0.000605	CcSEcCtD
Haloperidol—Convulsion—Topiramate—obesity	7.48e-05	0.000601	CcSEcCtD
Haloperidol—Hypertension—Topiramate—obesity	7.46e-05	0.000599	CcSEcCtD
Haloperidol—ABCB1—liver—obesity	7.42e-05	0.00202	CbGeAlD
Haloperidol—Anxiety—Topiramate—obesity	7.33e-05	0.000589	CcSEcCtD
Haloperidol—Dizziness—Bupropion—obesity	7.32e-05	0.000588	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	7.3e-05	0.000587	CcSEcCtD
Haloperidol—Dry mouth—Topiramate—obesity	7.19e-05	0.000578	CcSEcCtD
Haloperidol—Confusional state—Topiramate—obesity	7.11e-05	0.000571	CcSEcCtD
Haloperidol—Oedema—Topiramate—obesity	7.05e-05	0.000566	CcSEcCtD
Haloperidol—Vomiting—Bupropion—obesity	7.03e-05	0.000565	CcSEcCtD
Haloperidol—Rash—Bupropion—obesity	6.98e-05	0.00056	CcSEcCtD
Haloperidol—Dermatitis—Bupropion—obesity	6.97e-05	0.00056	CcSEcCtD
Haloperidol—Headache—Bupropion—obesity	6.93e-05	0.000557	CcSEcCtD
Haloperidol—Nervous system disorder—Topiramate—obesity	6.91e-05	0.000555	CcSEcCtD
Haloperidol—Thrombocytopenia—Topiramate—obesity	6.9e-05	0.000554	CcSEcCtD
Haloperidol—Tachycardia—Topiramate—obesity	6.88e-05	0.000553	CcSEcCtD
Haloperidol—Skin disorder—Topiramate—obesity	6.85e-05	0.00055	CcSEcCtD
Haloperidol—Hyperhidrosis—Topiramate—obesity	6.81e-05	0.000547	CcSEcCtD
Haloperidol—Anorexia—Topiramate—obesity	6.72e-05	0.00054	CcSEcCtD
Haloperidol—Hypotension—Topiramate—obesity	6.59e-05	0.000529	CcSEcCtD
Haloperidol—Nausea—Bupropion—obesity	6.57e-05	0.000528	CcSEcCtD
Haloperidol—Insomnia—Topiramate—obesity	6.37e-05	0.000512	CcSEcCtD
Haloperidol—Dyspnoea—Topiramate—obesity	6.28e-05	0.000505	CcSEcCtD
Haloperidol—Somnolence—Topiramate—obesity	6.27e-05	0.000503	CcSEcCtD
Haloperidol—Dyspepsia—Topiramate—obesity	6.2e-05	0.000498	CcSEcCtD
Haloperidol—Decreased appetite—Topiramate—obesity	6.13e-05	0.000492	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Topiramate—obesity	6.08e-05	0.000489	CcSEcCtD
Haloperidol—Constipation—Topiramate—obesity	6.03e-05	0.000484	CcSEcCtD
Haloperidol—Feeling abnormal—Topiramate—obesity	5.81e-05	0.000467	CcSEcCtD
Haloperidol—Urticaria—Topiramate—obesity	5.6e-05	0.00045	CcSEcCtD
Haloperidol—Body temperature increased—Topiramate—obesity	5.57e-05	0.000448	CcSEcCtD
Haloperidol—Hypersensitivity—Topiramate—obesity	5.19e-05	0.000417	CcSEcCtD
Haloperidol—Pruritus—Topiramate—obesity	4.99e-05	0.000401	CcSEcCtD
Haloperidol—Diarrhoea—Topiramate—obesity	4.82e-05	0.000387	CcSEcCtD
Haloperidol—Dizziness—Topiramate—obesity	4.66e-05	0.000374	CcSEcCtD
Haloperidol—Vomiting—Topiramate—obesity	4.48e-05	0.00036	CcSEcCtD
Haloperidol—Rash—Topiramate—obesity	4.44e-05	0.000357	CcSEcCtD
Haloperidol—Dermatitis—Topiramate—obesity	4.44e-05	0.000357	CcSEcCtD
Haloperidol—Headache—Topiramate—obesity	4.42e-05	0.000355	CcSEcCtD
Haloperidol—Nausea—Topiramate—obesity	4.19e-05	0.000336	CcSEcCtD
Haloperidol—CYP1A2—Metabolism—GNB3—obesity	1.08e-06	9.41e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARGC1A—obesity	1.08e-06	9.41e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MAPK8—obesity	1.08e-06	9.41e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AGT—obesity	1.08e-06	9.4e-06	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—PIK3CA—obesity	1.08e-06	9.39e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AKT1—obesity	1.08e-06	9.38e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SERPINE1—obesity	1.08e-06	9.38e-06	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—PIK3CA—obesity	1.08e-06	9.37e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—HMOX1—obesity	1.08e-06	9.36e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SERPINE1—obesity	1.08e-06	9.36e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ALB—obesity	1.08e-06	9.33e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MAPK8—obesity	1.07e-06	9.28e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TYK2—obesity	1.07e-06	9.27e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AKT1—obesity	1.07e-06	9.26e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—FASN—obesity	1.07e-06	9.25e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOE—obesity	1.06e-06	9.21e-06	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MYC—obesity	1.06e-06	9.21e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—BCHE—obesity	1.06e-06	9.21e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RHOA—obesity	1.06e-06	9.2e-06	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TGFB1—obesity	1.06e-06	9.19e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AGT—obesity	1.06e-06	9.18e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GNAS—obesity	1.06e-06	9.16e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CAV1—obesity	1.05e-06	9.13e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TYK2—obesity	1.05e-06	9.12e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—STAT3—obesity	1.05e-06	9.12e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOA1—obesity	1.05e-06	9.11e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TYK2—obesity	1.05e-06	9.1e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MTHFR—obesity	1.05e-06	9.1e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOS3—obesity	1.05e-06	9.1e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3R1—obesity	1.05e-06	9.1e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RHOA—obesity	1.04e-06	9.05e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RHOA—obesity	1.04e-06	9.03e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MTHFR—obesity	1.04e-06	9.02e-06	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MYC—obesity	1.04e-06	9.02e-06	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TGFB1—obesity	1.04e-06	9e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOE—obesity	1.04e-06	8.99e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOB—obesity	1.03e-06	8.97e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3R1—obesity	1.03e-06	8.96e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOS3—obesity	1.03e-06	8.96e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3R1—obesity	1.03e-06	8.94e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOS3—obesity	1.03e-06	8.94e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3CD—obesity	1.03e-06	8.93e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARA—obesity	1.03e-06	8.93e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3R1—obesity	1.03e-06	8.93e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—NOS3—obesity	1.03e-06	8.93e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CAV1—obesity	1.03e-06	8.91e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOA1—obesity	1.02e-06	8.89e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP2E1—obesity	1.02e-06	8.89e-06	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MYC—obesity	1.02e-06	8.88e-06	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TGFB1—obesity	1.02e-06	8.85e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARA—obesity	1.02e-06	8.85e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ALB—obesity	1.02e-06	8.82e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NQO1—obesity	1.01e-06	8.79e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.01e-06	8.72e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—PIK3CA—obesity	9.99e-07	8.67e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AGT—obesity	9.97e-07	8.65e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—STAT3—obesity	9.91e-07	8.6e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AGT—obesity	9.88e-07	8.57e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—LPL—obesity	9.87e-07	8.57e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—PIK3CA—obesity	9.83e-07	8.53e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—PIK3CA—obesity	9.81e-07	8.51e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—STAT3—obesity	9.78e-07	8.48e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOE—obesity	9.77e-07	8.47e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MYC—obesity	9.76e-07	8.47e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TGFB1—obesity	9.74e-07	8.45e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3R1—obesity	9.72e-07	8.44e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—NOS3—obesity	9.72e-07	8.44e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GCG—obesity	9.71e-07	8.42e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SLC2A4—obesity	9.71e-07	8.42e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOE—obesity	9.68e-07	8.4e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MTOR—obesity	9.68e-07	8.4e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3CB—obesity	9.68e-07	8.4e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CAV1—obesity	9.68e-07	8.4e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOA1—obesity	9.65e-07	8.38e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GPX1—obesity	9.63e-07	8.36e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CAV1—obesity	9.59e-07	8.32e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CG—obesity	9.58e-07	8.32e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYCS—obesity	9.58e-07	8.31e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOA1—obesity	9.57e-07	8.31e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3CB—obesity	9.53e-07	8.27e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MTOR—obesity	9.53e-07	8.27e-06	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PIK3CA—obesity	9.52e-07	8.26e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3CB—obesity	9.51e-07	8.25e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MTOR—obesity	9.51e-07	8.25e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3CB—obesity	9.5e-07	8.24e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—obesity	9.41e-07	8.17e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GOT1—obesity	9.4e-07	8.16e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GGT1—obesity	9.4e-07	8.16e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CD36—obesity	9.38e-07	8.14e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CG—obesity	9.35e-07	8.12e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NCOA1—obesity	9.26e-07	8.04e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARG—obesity	9.25e-07	8.03e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MYC—obesity	9.21e-07	7.99e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TGFB1—obesity	9.19e-07	7.97e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.16e-07	7.95e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—STK11—obesity	9.13e-07	7.92e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP19A1—obesity	9.13e-07	7.92e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—POMC—obesity	9.12e-07	7.92e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MYC—obesity	9.09e-07	7.88e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—INS—obesity	9.07e-07	7.87e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TGFB1—obesity	9.06e-07	7.86e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARG—obesity	9.03e-07	7.83e-06	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PIK3CA—obesity	9.01e-07	7.82e-06	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AKT1—obesity	8.99e-07	7.8e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3CB—obesity	8.97e-07	7.79e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—POMC—obesity	8.9e-07	7.73e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—obesity	8.89e-07	7.72e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MTHFR—obesity	8.89e-07	7.71e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—INS—obesity	8.85e-07	7.68e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6—obesity	8.85e-07	7.68e-06	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AKT1—obesity	8.84e-07	7.67e-06	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AKT1—obesity	8.82e-07	7.66e-06	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PIK3CA—obesity	8.82e-07	7.66e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CG—obesity	8.81e-07	7.65e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CG—obesity	8.74e-07	7.58e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARA—obesity	8.72e-07	7.57e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6—obesity	8.7e-07	7.55e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6—obesity	8.69e-07	7.54e-06	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PIK3CA—obesity	8.68e-07	7.53e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARG—obesity	8.51e-07	7.38e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—COMT—obesity	8.49e-07	7.36e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AGT—obesity	8.44e-07	7.33e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARG—obesity	8.43e-07	7.32e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CD—obesity	8.42e-07	7.31e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MMP9—obesity	8.41e-07	7.3e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—POMC—obesity	8.39e-07	7.28e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GNB3—obesity	8.37e-07	7.26e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARGC1A—obesity	8.37e-07	7.26e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—INS—obesity	8.34e-07	7.24e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—HMOX1—obesity	8.33e-07	7.23e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—POMC—obesity	8.32e-07	7.22e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ALB—obesity	8.32e-07	7.22e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PIK3CA—obesity	8.29e-07	7.19e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MMP9—obesity	8.28e-07	7.18e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOE—obesity	8.27e-07	7.18e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—INS—obesity	8.27e-07	7.18e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MMP9—obesity	8.26e-07	7.17e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CD—obesity	8.22e-07	7.14e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CAV1—obesity	8.2e-07	7.11e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MAPK8—obesity	8.18e-07	7.1e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOA1—obesity	8.18e-07	7.1e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AKT1—obesity	8.16e-07	7.08e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GNAS—obesity	8.15e-07	7.07e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ALB—obesity	8.12e-07	7.04e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MAPK8—obesity	8.05e-07	6.99e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MAPK8—obesity	8.03e-07	6.97e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AKT1—obesity	8.03e-07	6.97e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AKT1—obesity	8.01e-07	6.95e-06	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PIK3CA—obesity	8.01e-07	6.95e-06	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6—obesity	7.98e-07	6.92e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOB—obesity	7.98e-07	6.92e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—NOS3—obesity	7.95e-07	6.9e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3R1—obesity	7.95e-07	6.9e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.83e-07	6.8e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PIK3CA—obesity	7.82e-07	6.78e-06	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6—obesity	7.81e-07	6.78e-06	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—AKT1—obesity	7.78e-07	6.75e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—NOS3—obesity	7.76e-07	6.74e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3R1—obesity	7.76e-07	6.74e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CD—obesity	7.75e-07	6.72e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PIK3CA—obesity	7.71e-07	6.69e-06	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6—obesity	7.69e-07	6.67e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CD—obesity	7.68e-07	6.67e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ALB—obesity	7.65e-07	6.64e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—LPL—obesity	7.62e-07	6.61e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ALB—obesity	7.58e-07	6.58e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—STAT3—obesity	7.48e-07	6.49e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CG—obesity	7.47e-07	6.48e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GPX1—obesity	7.43e-07	6.45e-06	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AKT1—obesity	7.36e-07	6.39e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—STAT3—obesity	7.36e-07	6.39e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—STAT3—obesity	7.35e-07	6.37e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CB—obesity	7.34e-07	6.37e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6—obesity	7.34e-07	6.37e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3R1—obesity	7.32e-07	6.35e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—NOS3—obesity	7.32e-07	6.35e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—obesity	7.28e-07	6.31e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3R1—obesity	7.25e-07	6.29e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—NOS3—obesity	7.25e-07	6.29e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CD36—obesity	7.24e-07	6.28e-06	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AKT1—obesity	7.21e-07	6.26e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARG—obesity	7.21e-07	6.25e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CB—obesity	7.17e-07	6.22e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—POMC—obesity	7.11e-07	6.17e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—obesity	7.1e-07	6.16e-06	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AKT1—obesity	7.09e-07	6.16e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—INS—obesity	7.07e-07	6.13e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MYC—obesity	6.95e-07	6.03e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TGFB1—obesity	6.94e-07	6.02e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6—obesity	6.92e-07	6.01e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MTHFR—obesity	6.86e-07	5.95e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MYC—obesity	6.84e-07	5.94e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6—obesity	6.83e-07	5.93e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MYC—obesity	6.83e-07	5.92e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TGFB1—obesity	6.82e-07	5.92e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TGFB1—obesity	6.81e-07	5.91e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AKT1—obesity	6.77e-07	5.88e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CB—obesity	6.75e-07	5.86e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARA—obesity	6.73e-07	5.84e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CB—obesity	6.7e-07	5.81e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—obesity	6.69e-07	5.81e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—obesity	6.63e-07	5.76e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CD—obesity	6.56e-07	5.7e-06	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—AKT1—obesity	6.54e-07	5.68e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AGT—obesity	6.52e-07	5.66e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ALB—obesity	6.48e-07	5.62e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AKT1—obesity	6.39e-07	5.54e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOE—obesity	6.39e-07	5.54e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CAV1—obesity	6.33e-07	5.49e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOA1—obesity	6.31e-07	5.48e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AKT1—obesity	6.3e-07	5.47e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NOS3—obesity	6.2e-07	5.38e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3R1—obesity	6.2e-07	5.38e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3CA—obesity	5.9e-07	5.12e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3CA—obesity	5.81e-07	5.04e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3CA—obesity	5.79e-07	5.03e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3CA—obesity	5.79e-07	5.02e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CG—obesity	5.76e-07	5e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CB—obesity	5.72e-07	4.96e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—obesity	5.67e-07	4.92e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARG—obesity	5.56e-07	4.83e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—POMC—obesity	5.49e-07	4.76e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3CA—obesity	5.47e-07	4.75e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—INS—obesity	5.45e-07	4.73e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6—obesity	5.23e-07	4.53e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6—obesity	5.14e-07	4.46e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6—obesity	5.13e-07	4.45e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CD—obesity	5.07e-07	4.4e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ALB—obesity	5e-07	4.34e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AKT1—obesity	4.82e-07	4.18e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NOS3—obesity	4.78e-07	4.15e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3R1—obesity	4.78e-07	4.15e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AKT1—obesity	4.74e-07	4.12e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AKT1—obesity	4.73e-07	4.11e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—AKT1—obesity	4.73e-07	4.1e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CA—obesity	4.48e-07	3.88e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—AKT1—obesity	4.47e-07	3.88e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CB—obesity	4.42e-07	3.83e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—obesity	4.38e-07	3.8e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CA—obesity	4.37e-07	3.79e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CA—obesity	4.12e-07	3.57e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CA—obesity	4.08e-07	3.54e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AKT1—obesity	3.66e-07	3.17e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AKT1—obesity	3.57e-07	3.1e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CA—obesity	3.49e-07	3.03e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AKT1—obesity	3.36e-07	2.92e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AKT1—obesity	3.33e-07	2.89e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AKT1—obesity	2.85e-07	2.47e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CA—obesity	2.69e-07	2.34e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AKT1—obesity	2.2e-07	1.91e-06	CbGpPWpGaD
